40
Participants
Start Date
May 23, 2023
Primary Completion Date
December 30, 2023
Study Completion Date
January 30, 2024
CardioFlux
CardioFlux MCG is a process that observes incremental changes in the heart's electrical activity by the magnetic fields generated by these currents. These magnetic fields have been used for decades via electrocardiogram to help diagnose and treat both acute and chronic cardiac pathology. The CardioFlux device reaches the potential of this phenomenon by sensing a complete magnetic field map. It is equipped with a magnetic shielding chamber and can attenuate magnetic field noise by a factor of nearly 1500 which maximizes signal to noise ratio. CardioFlux is an easy to operate, noninvasive modality that can detect the presence of ischemic cardiac tissue in symptomatic patients in a less than 5-minute scan. The device uses the proprietary software called Faraday which processes MCG scans, create diagnostic functional images, and run analytics.
RECRUITING
The Cleveland Clinic, Cleveland
Lead Sponsor
The Cleveland Clinic
OTHER
Genetesis Inc.
INDUSTRY